Biotechnology - USA

Filter

Current filters:

USA

Popular Filters

1 to 25 of 216 results

Harvoni will keep Gilead atop hepatitis C treatment landscape, says analyst

Harvoni will keep Gilead atop hepatitis C treatment landscape, says analyst

23-10-2014

The recent US Food and Drug Administration approval of Harvoni (ledipasvir/sofosbuvir), Gilead Sciences’…

Anti-viralsBiotechnologyGilead SciencesHarvoniMarkets & MarketingPricingSovaldiUSA

Biogen Idec third-qtr net rockets 76% but shares slump

Biogen Idec third-qtr net rockets 76% but shares slump

23-10-2014

US biotech firm Biogen Idec saw its share price plunge 7% to $303.51, after its posted third-quarter…

Biogen IdecBiotechnologyFinancialNeurologicalTecfideraUSA

aTyr Pharma appoints John McKew as vice president of research

aTyr Pharma appoints John McKew as vice president of research

22-10-2014

US rare disease company aTyr Pharma has named John McKew as vice president of research.

aTyrBiotechnologyBoardroomNational Institutes of HealthUSA

FDA advisory backs expanded use of Vertex’ CF drug

22-10-2014

There was good news for US biotech firm Vertex Pharmaceuticals yesterday, as a US Food and Drug Administration…

BiotechnologyKalydecoRare diseasesRegulationUSAVertex Pharmaceuticals

Immune Pharma funds study supporting bertilimumab use in irritable bowel syndrome

Immune Pharma funds study supporting bertilimumab use in irritable bowel syndrome

22-10-2014

US-Israeli Immune Pharmaceuticals has funded a study yielding clinical data to demonstrate the importance…

BiotechnologyGastro-intestinalsImmune PharmaceuticalsIsraelResearchUSA

PhosImmune and PureMHC to collaborate on antibody-based immunotherapies for cancer

PhosImmune and PureMHC to collaborate on antibody-based immunotherapies for cancer

22-10-2014

Clinical-stage oncology biotech company PhosImmune has entered into a license and collaboration agreement…

BiotechnologyLicensingOncologyPhosImmunePureMHCUSA

Auxilium's supplemental Biologics Application for Xiaflex approved by FDA

Auxilium's supplemental Biologics Application for Xiaflex approved by FDA

21-10-2014

Specialty biopharma company Auxilium Pharmaceuticals has received approval from the US Food And Drug…

Anti-Arthritics/RheumaticsAuxilium PharmaceuticalsBiotechnologyRegulationUSAXiaflex

ZMapp Ebola medication will improve public understanding of drug production, says Kalorama

ZMapp Ebola medication will improve public understanding of drug production, says Kalorama

20-10-2014

Mapp Biopharma’s ZMapp Ebola therapy will enhance public understanding of the drug development process,…

Antibiotics and Infectious diseasesBiotechnologyMapp BiopharmaceuticalResearchUSAZMapp

Amgen sues Sanofi and Regeneron over alleged patent infringement

19-10-2014

USA-based Amgen has filed a law suit in the US District Court of Delaware against French pharma major…

alirocumabAmgenBiotechnologyCardio-vascularevolocumabLegalPatentsRegeneron PharmaceuticalsSanofiUSA

Profectus BioSciences gets US government funding for Ebola vaccine development

17-10-2014

Under a one-year contract with US biotech firm Profectus BioSciences, the US Department of Health and…

Anti-viralsBiotechnologyFinancialProfectus BioSciencesResearchUSA

Selecta, JDRF and Sanofi collaborate to develop SVP for type 1 diabetes

Selecta, JDRF and Sanofi collaborate to develop SVP for type 1 diabetes

17-10-2014

US clinical-stage biopharma company Selecta Biosciences and JDRF have extended their joint research collaboration…

BiotechnologyDiabetesFranceResearchSanofiSelecta BiosciencesUSA

FDA approves Gilead’s Harvoni, the first combo pill for hepatitis C

FDA approves Gilead’s Harvoni, the first combo pill for hepatitis C

12-10-2014

As was largely expected, the US Food and Drug Administration on Friday approved biotech firm Gilead Sciences’…

Anti-viralsBiotechnologyGilead SciencesHarvoniPricingRegulationSovaldiUSA

DelMar's lead compound VAL-083 data shows potential to be superior to current treatments in NSCLC

DelMar's lead compound VAL-083 data shows potential to be superior to current treatments in NSCLC

10-10-2014

Clinical stage oncology company DelMar Pharmaceuticals’ lead drug compound VAL-083 has demonstrated…

BiotechnologyDelMar PharmaceuticalsOncologyResearchUSAVAL-083

US orphan designation for DNAtrix’ DNX-2401 in malignant glioma

US orphan designation for DNAtrix’ DNX-2401 in malignant glioma

09-10-2014

US privately-held oncolytic virus expert DNAtrix says that the US Food and Drug Administration has granted…

BiotechnologyDNAtrixDNX-2401OncologyRegulationUSA

Chimerix reports preliminary data showing antiviral brincidofovir improves survival in adenovirus

Chimerix reports preliminary data showing antiviral brincidofovir improves survival in adenovirus

09-10-2014

Antiviral biopharma company Chimerix has reported preliminary data indicating that its investigational…

Anti-viralsBiotechnologybrincidofovirChimerixResearchUSA

New Coronado Biosciences unit to acquire and license dermatology products for commercialization

New Coronado Biosciences unit to acquire and license dermatology products for commercialization

08-10-2014

US biopharma company Coronado Biosciences has formed a wholly-owned subsidiary, Journey Medical Corporation…

BiotechnologyCoronado BiosciencesDermatologicalsJourney Medical CorpLicensingManagementUSA

Cardio3 Biosciences gains preferred access to all Mayo Clinic regenerative medicine portfolio

Cardio3 Biosciences gains preferred access to all Mayo Clinic regenerative medicine portfolio

08-10-2014

Belgium biotech firm Cardio3 BioSciences says it has signed a preferred access agreement with the USA’s…

BelgiumBiotechnologyC-CureCardio-vascularCardio3 BioSciencesResearchUSA

US FDA grants Fast Track status to BrainStorm Cell Therapeutics for ALS treatment NurOwn

US FDA grants Fast Track status to BrainStorm Cell Therapeutics for ALS treatment NurOwn

07-10-2014

The US Food and Drug Administration has designated a product from stem cell treatment developer BrainStorm…

BiotechnologyBrainStorm Cell TherapeuticsNeurologicalNurOwnRegulationUSA

Regeneron gains further FDA indications for Eylea

Regeneron gains further FDA indications for Eylea

07-10-2014

The US Food and Drug Administration has approved biotech firm Regeneron Pharmaceuticals’ Eylea (aflibercept)…

BayerBiotechnologyEyleaOphthalmicsRegeneron PharmaceuticalsRegulationUSA

PDL BioPharma appoints Danny Hart as vice president of business development

PDL BioPharma appoints Danny Hart as vice president of business development

06-10-2014

PDL BioPharma has appointed Danny Hart as vice president of business development.

BiotechnologyBoardroomDanny HartPDL BioPharmaUSA

Orphan status for Horizon Pharma’s Actimmune in Friedreich's ataxia

Orphan status for Horizon Pharma’s Actimmune in Friedreich's ataxia

04-10-2014

The US Food and Drug Administration has granted orphan drug designation for Ireland-headquartered specialty…

ActimmuneBiotechnologyHorizon PharmaRare diseasesRegulationUSA

1 to 25 of 216 results

Back to top